Vaccine equity: Past, present, and future

The term “vaccine equity” primarily points to the enormous imbalance in global COVID-19 vaccine distribution. Vaccine equity should adopt a normative approach toward “health equity,” and various stakeholders across the vaccine life cycle must practice it. The momentum gathered during this pandemic m...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Graaf, Rieke, Browne, Joyce L., Baidjoe, Amrish Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831140/
https://www.ncbi.nlm.nih.gov/pubmed/35474741
http://dx.doi.org/10.1016/j.xcrm.2022.100551
_version_ 1784648436677607424
author van der Graaf, Rieke
Browne, Joyce L.
Baidjoe, Amrish Y.
author_facet van der Graaf, Rieke
Browne, Joyce L.
Baidjoe, Amrish Y.
author_sort van der Graaf, Rieke
collection PubMed
description The term “vaccine equity” primarily points to the enormous imbalance in global COVID-19 vaccine distribution. Vaccine equity should adopt a normative approach toward “health equity,” and various stakeholders across the vaccine life cycle must practice it. The momentum gathered during this pandemic must be used to correct these structural imbalances.
format Online
Article
Text
id pubmed-8831140
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-88311402022-02-11 Vaccine equity: Past, present, and future van der Graaf, Rieke Browne, Joyce L. Baidjoe, Amrish Y. Cell Rep Med Commentary The term “vaccine equity” primarily points to the enormous imbalance in global COVID-19 vaccine distribution. Vaccine equity should adopt a normative approach toward “health equity,” and various stakeholders across the vaccine life cycle must practice it. The momentum gathered during this pandemic must be used to correct these structural imbalances. Elsevier 2022-02-11 /pmc/articles/PMC8831140/ /pubmed/35474741 http://dx.doi.org/10.1016/j.xcrm.2022.100551 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
van der Graaf, Rieke
Browne, Joyce L.
Baidjoe, Amrish Y.
Vaccine equity: Past, present, and future
title Vaccine equity: Past, present, and future
title_full Vaccine equity: Past, present, and future
title_fullStr Vaccine equity: Past, present, and future
title_full_unstemmed Vaccine equity: Past, present, and future
title_short Vaccine equity: Past, present, and future
title_sort vaccine equity: past, present, and future
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831140/
https://www.ncbi.nlm.nih.gov/pubmed/35474741
http://dx.doi.org/10.1016/j.xcrm.2022.100551
work_keys_str_mv AT vandergraafrieke vaccineequitypastpresentandfuture
AT brownejoycel vaccineequitypastpresentandfuture
AT baidjoeamrishy vaccineequitypastpresentandfuture

Ejemplares similares